Abstract
Dr. Wolfe compares recent advertising claims of drug manufacturers with the National Academy of Sciences' drug efficacy studies. He stresses the need for several major revisions of drug advertising techniques and urges the FDA to assume surveillance over the content of material and presentations used by drug detail men. He also advocates that people should be encouraged to ask their doctors why a particular drug is being prescribed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 249-253 |
| Number of pages | 5 |
| Journal | Journal of Drug Issues |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jan 1 1974 |
| Externally published | Yes |
ASJC Scopus subject areas
- Medicine (miscellaneous)
- Health(social science)
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health
Fingerprint Dive into the research topics of 'Scientific evaluations dispute advertising claims'. Together they form a unique fingerprint.
Cite this
Wolfe, S. M. (1974). Scientific evaluations dispute advertising claims. Journal of Drug Issues, 4(3), 249-253. https://doi.org/10.1177/002204267400400312